Studies point way to new therapeutic prospects for muscular dystrophy.
Kuehn
Bridget M
BM
D000818:Animals; D018389:Codon, Nonsense; D016189:Dystrophin / Q000096:biosynthesis; D015870:Gene Expression; D006801:Humans; D019808:Losartan / Q000627:therapeutic use*; D008382:Marfan Syndrome / Q000188:drug therapy; D051379:Mice; D020388:Muscular Dystrophy, Duchenne / Q000188:drug therapy* / Q000235:genetics; D010069:Oxadiazoles / Q000627:therapeutic use*; D047493:PPAR alpha / Q000096:biosynthesis; D016212:Transforming Growth Factor beta / Q000037:antagonists & inhibitors
D018389:Codon, Nonsense; D016189:Dystrophin; D010069:Oxadiazoles; D047493:PPAR alpha; D016212:Transforming Growth Factor beta; D019808:Losartan; C515878:ataluren